{
  "id": 3625,
  "text": "J., et al.A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.Gynecol Oncol 116, 163-167 (2010).1619.Tinker, A.V., et al.Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: J., et al.A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.Gynecol Oncol 116, 163-167 (2010).1619.Tinker, A.V., et al.Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix.\n\n<question>: ",
  "ChatGPT_response_0": "在这些研究中，研究人员使用了舒尼替尼和替美罗苹果酸酯这两种药物来治疗晚期宫颈癌患者。舒尼替尼和替美罗苹果酸酯是常用于治疗一些癌症的药物，通过调节细胞的生长和分裂来抑制肿瘤的发展。这些药物在临床试验中展现出一定的疗效，但需要在医生的指导下进行使用，并结合其他治疗手段来提高疗效及减少不良反应的发生。如果您或您认识的人患有晚期宫颈癌，建议咨询医生以获取最合适的治疗方案。",
  "query": "这个研究中，哪种药物被用于治疗晚期宫颈癌患者？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这个研究中，哪种药物被用于治疗晚期宫颈癌患者？\n\n<reference text>: J., et al.A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.Gynecol Oncol 116, 163-167 (2010).1619.Tinker, A.V., et al.Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix.\n\n<reply>: ",
  "response": "在这些研究中，研究人员使用了舒尼替尼和替美罗苹果酸酯这两种药物来治疗晚期宫颈癌患者。舒尼替尼和替美罗苹果酸酯是常用于治疗一些癌症的药物，通过调节细胞的生长和分裂来抑制肿瘤的发展。这些药物在临床试验中展现出一定的疗效，但需要在医生的指导下进行使用，并结合其他治疗手段来提高疗效及减少不良反应的发生。如果您或您认识的人患有晚期宫颈癌，建议咨询医生以获取最合适的治疗方案。"
}